or Try an Advanced Search...

    Technical Analysis for CPRX - Catalyst Pharmaceutical Partners, Inc.

    Grade Last Price % Change Price Change
    C 16.49 0.55% 0.09
    CPRX closed up 0.55 percent on Friday, May 17, 2024, on 87 percent of normal volume.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical CPRX trend table...
    Date Alert Name Type % Chg
    Upper Bollinger Band Walk Strength 0.00%
    Outside Day Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Stochastic Sell Signal Bearish 0.55%
    NR7 Range Contraction 0.55%
    Upper Bollinger Band Walk Strength 0.55%
    Overbought Stochastic Strength 0.55%
    Upper Bollinger Band Touch Strength 0.55%
    Older End-of-Day Signals for CPRX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 1 day ago
    Outside Day 1 day ago
    Rose Above Upper Bollinger Band 1 day ago
    Up 2% 1 day ago
    Upper Bollinger Band Resistance 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CPRX Chart by TradingView
    Basic chart:

    Profile

    Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. The company's principal product includes Firdapse that is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. It also develops CPP-115, a GABA aminotransferase inhibitor for the treatment of epilepsy and other selected central nervous disease indications; and CPP-109 for the treatment of Tourette Syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Health Sciences Medication Virotherapy Disorders Epilepsy Pharmaceutical Sciences Prescription Drugs Stage Specialty Pharmaceutical Myasthenia Pharmaceutical Partners Treatment Of Epilepsy Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Tourette Syndrome Treatment Of Tourette Syndrome Urological Diseases

    Is CPRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
    May 9 HHS panel to vote in Nov. on DMD screening for newborns
    May 9 Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript
    May 8 Catalyst Pharmaceuticals Non-GAAP EPS of $0.38 beats by $0.08, revenue of $98.44M misses by $0.33M
    May 8 Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
    May 7 Catalyst Pharmaceuticals Q1 2024 Earnings Preview
    May 2 Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    May 1 Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
    May 1 Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024
    Apr 24 Dirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026
    See more CPRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.495
    52 Week Low 11.09
    Average Volume 1,270,115
    200-Day Moving Average 14.37
    50-Day Moving Average 15.68
    20-Day Moving Average 15.42
    10-Day Moving Average 15.87
    Average True Range 0.59
    RSI (14) 61.09
    ADX 19.04
    +DI 25.11
    -DI 13.23
    Chandelier Exit (Long, 3 ATRs) 15.27
    Chandelier Exit (Short, 3 ATRs) 16.23
    Upper Bollinger Bands 16.75
    Lower Bollinger Band 14.09
    Percent B (%b) 0.9
    BandWidth 17.28
    MACD Line 0.28
    MACD Signal Line 0.10
    MACD Histogram 0.182
    Fundamentals Value
    Market Cap 1.96 Billion
    Num Shares 119 Million
    EPS 0.55
    Price-to-Earnings (P/E) Ratio 29.98
    Price-to-Sales 4.66
    Price-to-Book 4.66
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 17.29
    Resistance 3 (R3) 17.32 17.09 17.16
    Resistance 2 (R2) 17.09 16.88 17.07 17.11
    Resistance 1 (R1) 16.79 16.76 16.67 16.76 17.07
    Pivot Point 16.55 16.55 16.49 16.54 16.55
    Support 1 (S1) 16.25 16.35 16.14 16.22 15.91
    Support 2 (S2) 16.02 16.22 16.00 15.87
    Support 3 (S3) 15.72 16.02 15.82
    Support 4 (S4) 15.69